Nutrition
Volume 26, Issue 2 , Pages 240-242 , February 2010

Role of an electronic armband in motor function monitoring in patients with Parkinson's disease

  • Emanuele Cereda, M.D.

      Affiliations

    • International Center for the Assessment of Nutritional Status (ICANS), Dipartimento di Scienze e Tecnologie Alimentari e Microbiologiche (DISTAM), Università degli Studi di Milano, Milan, Italy
    • Parkinson Institute, Istituti Clinici di Perfezionamento, Milan, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39-02-503-16079; fax: +39-02-503-16077.
  • ,
  • Gianni Pezzoli, M.D.

      Affiliations

    • Parkinson Institute, Istituti Clinici di Perfezionamento, Milan, Italy
  • ,
  • Michela Barichella, M.D.

      Affiliations

    • Parkinson Institute, Istituti Clinici di Perfezionamento, Milan, Italy

Received 5 March 2009 ,Accepted 1 June 2009.

References 

  1. Schapira AHV. Parkinson's disease. BMJ. 1999;318:311–314
  2. Fox SH, Lang AE. Levodopa-related motor complications—phenomenology. Mov Disord. 2008;23(suppl 3):S509–S514
  3. Barichella M, Cereda E, Pezzoli G. Major nutritional issues in the management of Parkinson's disease. Mov Disord. 2009;(in press)
  4. Mignault D, St-Onge M, Karelis AD, Allison DB, Rabasa-Lhoret R. Evaluation of the portable HealthWear armband: a device to measure total daily energy expenditure in free-living type 2 diabetic individuals. Diabetes Care. 2005;28:225–227
  5. Cereda E, Turrini M, Ciapanna D, Marbello L, Pietrobelli A, Corradi E. Assessing energy expenditure in cancer patients: a pilot validation of a new wearable device. JPEN. 2007;31:502–507
  6. Barichella M, Marczewska A, De Notaris R, Sieri S, Barichella M, Fusconi E, et al. Special low-protein foods ameliorate postprandial off in patients with advanced Parkinson's disease. Mov Disord. 2006;21:1682–1687
  7. Wooten GF. Pharmacokinetics of LevoDOPA. In:  Marsden CD,  Fahn S editor. Movement disorders. Volume 2. London: Butterworth; 1987;p. 231–248
  8. Riley D, Lang AE. Practical application of a low-protein diet for Parkinson's disease. Neurology. 1988;38:1026–1031
  9. Carter JH, Nutt JG, Woodward WR, Hatcher LF, Tratman TL. Amount and distribution of dietary protein affects clinical response to Levodopa in Parkinson's disease. Neurology. 1989;39:552–556
  10. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000;32(Suppl):S498–S504
  11. Delikanaki-Skaribas E, Trail M, Wong WW, Lai EC. Daily energy expenditure, physical activity, and weight loss in Parkinson's disease patients. Mov Disord. 2009;24:667–671
  12. Barichella M, Marczewska AM, Mariani C, Landi A, Vairo A, Pezzoli G. Body weight gain rate in patients with Parkinson's disease and deep brain stimulation. Mov Disord. 2003;18:1337–1340
  13. Van Someren EJ, Pticek MD, Speelman JD, Schuurman PR, Esselink R, Swaab DF. New actigraph for long-term tremor recording. Mov Disord. 2006;21:1136–1143
  14. Paré S, Barr SI, Ross SE. Effect of daytime protein restriction on nutrient intakes of free-living Parkinson's disease patients. Am J Clin Nutr. 1992;55:701–707

 This study was supported by the Fondazione Grigioni per il morbo di Parkinson (Milan, Italy).

PII: S0899-9007(09)00249-4

doi: 10.1016/j.nut.2009.06.003

Nutrition
Volume 26, Issue 2 , Pages 240-242 , February 2010